Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(14%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_4
1
14%
Ph phase_3
1
14%
Ph early_phase_1
1
14%
Ph not_applicable
2
29%
Ph phase_2
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(3)

Detailed Status

unknown3
Withdrawn1
Recruiting1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

withdrawn114%
recruiting114%
unknown343%
completed114%
not_yet_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7